Effect of parathyroidectomy on osteopontin and undercarboxylated osteocalcin in patients with primary hyperparathyroidism

References

• Shindo M, Lee JA, Lubitz CC, et al. The changing landscape of primary, secondary, and tertiary hyperparathyroidism: highlights from the American College of Surgeons Panel, “What’s new for the surgeon caring for patients with hyperparathyroidism”. J Am Coll Surg. 2016;222:1240–1250. doi:10.1016/j.jamcollsurg.2016.02.024.
   PubMed Web of Science ®Google Scholar
• Stilgren LS, Hegedus LM, Beck-Nielsen H, Abrahamsen B. Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. Calcif Tissue Int. 2003;73:210–216. doi:10.1007/s00223-002-2100-8.
   PubMed Web of Science ®Google Scholar
• Booth SL, Centi A, Smith SR, Gundberg C. The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol. 2013;9:43–55. doi:10.1038/nrendo.2012.201.
   PubMed Web of Science ®Google Scholar
• Ivaska KK, Hentunen TA, Vaaraniemi J, et al. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem. 2004;279:18361–18369. doi:10.1074/jbc.M314324200.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang H, Yang C, et al. An overview of osteocalcin progress. J Bone Miner Metab. 2016;34:367–379. doi:10.1007/s00774-015-0734-7.
   PubMed Web of Science ®Google Scholar
• Kim YS, Paik IY, Rhie YJ, et al. Integrative physiology: defined novel metabolic roles of osteocalcin. J Korean Med Sci. 2010;25:985–991. doi:10.3346/jkms.2010.25.7.985.
   PubMed Web of Science ®Google Scholar
• Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–469. doi:10.1016/j.cell.2007.05.047.
   PubMed Web of Science ®Google Scholar
• Lacombe J, Ferron M. Gamma-carboxylation regulates osteocalcin function. Oncotarget. 2015;6:19924–19925. doi:10.18632/oncotarget.v6i24.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang B, Xu Y, et al. The relationship between serum osteocalcin concentration and glucose metabolism in patients with type 2 diabetes mellitus. Int J Endocrinol. 2013;2013:842598. doi:10.1155/2013/842598.
   PubMed Web of Science ®Google Scholar
• Liu DM, Guo XZ, Tong HJ, et al. Association between osteocalcin and glucose metabolism: a meta-analysis. Osteoporos Int. 2015;26:2823–2833. doi:10.1007/s00198-015-3197-8.
   PubMed Web of Science ®Google Scholar
• Subraman V, Thiyagarajan M, Malathi N, et al. OPN -revisited. J Clin Diagn Res. 2015;9:ZE10–ZE13. doi:10.7860/JCDR/2015/12872.6111.
   PubMed Web of Science ®Google Scholar
• Kostenuik PJ. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol. 2005;5:618–625. doi:10.1016/j.coph.2005.06.005.
   PubMed Web of Science ®Google Scholar
• Rosenquist C, Fledelius C, Christgau S, et al. Serum crossLaps one step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem. 1998;44:2281–2289.
   PubMed Web of Science ®Google Scholar
• Kitahara K, Ishijima M, Rittling SR, et al. Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology. 2003;144:2132–2140. doi:10.1210/en.2002-220996.
   PubMed Web of Science ®Google Scholar
• Catalan V, Gomez-Ambrosi J, Rodriguez A, et al. Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin. Genes Nutr. 2015;10:11. doi:10.1007/s12263-015-0460-8.
   PubMed Web of Science ®Google Scholar
• Lancha A, Rodriguez A, Catalan V, et al. Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice. PLoS One. 2014;9:e98398. doi:10.1371/journal.pone.0098398.
   PubMed Web of Science ®Google Scholar
• Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology. 1999;140:3552–3561. doi:10.1210/endo.140.8.6887.
   PubMed Web of Science ®Google Scholar
• Verheyen N, Fahrleitner-Pammer A, Belyavskiy E, et al. Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: the EPATH trial. PLoS One. 2017;12:e0173799. doi:10.1371/journal.pone.0173799.
   PubMed Web of Science ®Google Scholar
• Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21:2191–2192. doi:10.2337/diacare.21.12.2191.
   PubMed Web of Science ®Google Scholar
• Confavreux CB. Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int Suppl. 2011;79:S14–S19. doi:10.1038/ki.2011.25.
   PubMed Web of Science ®Google Scholar
• Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142:296–308. doi:10.1016/j.cell.2010.06.003.
   PubMed Web of Science ®Google Scholar
• Iwadate H, Kobayashi H, Kanno T, et al. Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients. Int J Rheum Dis. 2014;17:50–56. doi:10.1111/1756-185X.12115.
   PubMed Web of Science ®Google Scholar
• Schuch K, Wanko B, Ambroz K, et al. Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties. Obesity. 2016;24:1489–1498. doi:10.1002/oby.21510.
   PubMed Web of Science ®Google Scholar
• Kerschan-Schindl K, Riss P, Krestan C, et al. Bone metabolism in patients with primary hyperparathyroidism before and after surgery. Horm Metab Res. 2012;44:476–481. doi:10.1055/s-0032-1308998.
   PubMed Web of Science ®Google Scholar
• Christiansen P, Steiniche T, Brixen K, et al. Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone. 1999;25:237–244. doi:10.1016/S8756-3282(99)00150-7.
   PubMed Web of Science ®Google Scholar
• Almqvist EG, Bondeson AG, Bondeson L, Svensson J. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism. Scand J Clin Lab Invest. 2011;71:139–144. doi:10.3109/00365513.2010.543694.
   PubMed Web of Science ®Google Scholar
• Tamura T, Udagawa N, Takahashi N, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci. 1993;90:11924–11928. doi:10.1073/pnas.90.24.11924.
   PubMed Web of Science ®Google Scholar
• Safley SA, Villinger F, Jackson EH, et al. Interleukin-6 production and secretion by human parathyroids. Clin Exp Immunol. 2004;136:145–156. doi:10.1111/j.1365-2249.2004.02419.x.
   PubMed Web of Science ®Google Scholar
• Abella V, Scotece M, Conde J, et al. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers. 2015;20:565–571. doi:10.3109/1354750X.2015.1123354.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Yoon HJ, Yoon KA, et al. Lipocalin-2 inhibits osteoclast formation by suppressing the proliferation and differentiation of osteoclast lineage cells. Exp Cell Res. 2015;334:301–309. doi:10.1016/j.yexcr.2015.03.008.
   PubMed Web of Science ®Google Scholar
• Rudman A, Pearson ER, Smith D, Srivastava R, Murphy MJ, Leese GP. Insulin resistance before and after parathyroidectomy in patients with primary hyperparathyroidism–a pilot study. Endocr Res. 2010;35:85–93. doi:10.3109/07435801003724503.
   PubMed Web of Science ®Google Scholar
• Bhadada SK, Bhansali A, Shah VN, et al. Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Singapore Med J. 2011;52:890–893.
   PubMed Web of Science ®Google Scholar
• Awazawa M, Ueki K, Inabe K, et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab. 2011;13:401–412. doi:10.1016/j.cmet.2011.02.010.
   PubMed Web of Science ®Google Scholar